HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Heartflow, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$51.02+2.73 (+5.65%)

Close on Oct 19, 2026

Market cap: $4.41B
P/E (TTM): –
Dividend yield: –

Dividends

Heartflow has not reported a dividend

No dividend per share appears in Heartflow's annual filings since fiscal 2022.

Where these numbers come from

Parsed from the XBRL in Heartflow's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HTFL.

Revenue growth42.8% · median 25.6%

Gross margin80.1% · median 76.8%

Operating margin-37.8% · median -58.5%

Net margin-55.8% · median -58.3%

Company	Revenue	Growth
IRTC	$825.34M	+25.6%
TCMD	$350.31M	+17.2%
HTFL	$212.08M	+42.8%
KMTS	$106.73M	+60.7%
CVRX	$61.19M	+12.0%
SI	$60.06M	+60.9%

Company

Next earnings (est.): Nov 11, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 843
Held by institutions: 86.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1464521

Advertisement
300 × 250